David Loebenberg
Impact in
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
- Microbiology top 5%
Papers in
- Pharmacology 43
- Microbial Natural Products and Biosynthesis 33
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Antifungal resistance and susceptibility 39
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Anthony F. Cacciapuoti (20 shared papers)Beth DiDomenico (4 shared papers)Julia R. Köhler (1 shared paper)Hsiu‐Jung Lo (1 shared paper)Gerald R. Fink (1 shared paper)Paul M. McNicholas (8 shared papers)Roberta S Hare (24 shared papers)Cara A. Mendrick (7 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (40 papers)The Journal of Antibiotics (26 papers)Journal of Antimicrobial Chemotherapy (7 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesMexicoVenezuela
In The Last Decade
David Loebenberg
102 papers receiving 5.3k citations
David Loebenberg's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 3k
- Microbiology 31
- Pharmacology 461
- Epidemiology 757
- Molecular Biology 1.3k
Countries citing papers authored by David Loebenberg
This map shows the geographic impact of David Loebenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loebenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loebenberg more than expected).
Fields of papers citing papers by David Loebenberg
This network shows the impact of papers produced by David Loebenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loebenberg. The network helps show where David Loebenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside David Loebenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonfilamentous C. albicans Mutants Are Avirulent Hit paper breakdown → | 1997 | 1605 |
| 2 | 2006 | 412 | |
| 3 | 2004 | 236 | |
| 4 | 2003 | 170 | |
| 5 | 2000 | 169 | |
| 6 | 2004 | 166 | |
| 7 | 2003 | 156 | |
| 8 | 1998 | 145 | |
| 9 | 2003 | 140 | |
| 10 | 2001 | 110 | |
| 11 | 2000 | 102 | |
| 12 | 2001 | 94 | |
| 13 | 2005 | 88 | |
| 14 | 1998 | 83 | |
| 15 | 2004 | 73 | |
| 16 | 1981 | 72 | |
| 17 | 1999 | 70 | |
| 18 | 1999 | 69 | |
| 19 | 2000 | 66 | |
| 20 | 2000 | 66 |
About David Loebenberg
David Loebenberg is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Small Animals and Molecular Medicine, having authored 107 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (39 papers), Microbial Natural Products and Biosynthesis (33 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Fungal Infections and Studies (9 papers), Helminth infection and control (5 papers), Antibiotic Resistance in Bacteria (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Infectious Diseases (3k citations), Microbiology (31 citations), Pharmacology (461 citations), Epidemiology (757 citations) and Molecular Biology (1.3k citations). David Loebenberg has collaborated with scholars based in United States, Mexico and Venezuela. Frequent co-authors include Anthony F. Cacciapuoti, Beth DiDomenico, Julia R. Köhler, Hsiu‐Jung Lo, Gerald R. Fink, Paul M. McNicholas, Roberta S Hare, Cara A. Mendrick, Andrew S. Chau and John R. Graybill. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Journal of Antimicrobial Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.